In the past decade, the Centre supported a total of 128 companies’ representatives on their road to access the Japanese market. Here are abstracts of 2 success stories by former participants. The whole interviews are available on our website.
Selvita – Poland
Selvita is a polish CRO (Contract Research Organisation) driven by a clear purpose: to bridge the gap between early drug discovery and the clinical stage of drug development by providing state of the art scientific support. Founded in 2007 as a small start-up in Poland, it has rapidly grown over the years to a global organisation, employing over 900 highly motivated specialists at six sites in four countries.
Novaptech – France
Novaptech, a French biotech SME, specializes in the development of aptamer-based tools and devices for applications across health, agri-food, and environmental sectors. Aptamers are artificially synthesized short sequences of DNA, RNA, or XNA designed to bind selectively to a specific target molecule or a family of target molecules.
Published: June 2024